Tag: aprevo
Carlsmed gains US FDA Breakthrough Device designation for Aprevo technology
Carlsmed recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for Aprevo—a technology used in the treatment of...
COMPaSS personalised spine surgery study begins enrolment
Carlsmed has revealed that the first patients have been enrolled in the COMPaSS study, a multicentre post market prospective observational registry which will collect data...
Carlsmed raises US$30M in Series B funding
Carlsmed recently announced that it has closed an oversubscribed US$30M Series B funding round, which will be used to ramp up commercialisation of aprevo,...
CMS grants transitional pass-through payment for Carlsmed’s aprevo personalised interbody devices
Carlsmed has announced that the Centre for Medicare and Medicaid Services (CMS) has granted its aprevo personalised interbody devices a transitional pass-through (TPT) payment...